 BOSTON and JERUSALEM, April 06, 2021 GLOBE NEWSWIRE -- Entera Bio Ltd. NASDAQ: ENTX, a leader in the development of orally delivered large molecule therapeutics, today announced the Company will deliver a poster presentation titled Pharmacokinetics of an Oral Human Growth Hormone hGH Formulation in Rats and Mice at the 31st Annual European Pharma Congress in London on April 28-29, 2021. 